Re-187-Oncardia

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRe-187-Oncardia
Drug Alias NameEC-G-[187Re]Rhenium-187-EC-G187Re-EC-G187Re-etylenedicysteine-glucosamine (Cell>Point)187Rhenium-EC-G (Cell>Point) +[6] 
ClassificationRadiation-emitting products > Radioactive therapeutic agentSmall molecules
Mechanisms of ActionDNA modulators
TargetsDNA
Therapy Area/IndicationsLymphoma, Mantle-CellLymphoma, Large B-Cell, Diffuse
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCellPoint LLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCellPoint LLC
Active IndicationsN/A
Inactive IndicationsLymphoma, Mantle-CellLymphoma, Large B-Cell, Diffuse

Other Information

ATC CodeN/A
Related LinksN/A